Skip to content

Active ingredient

Dantrolene

27 finished FDA listings contain Dantrolene as their only active ingredient.

FDA NDC Directory

Ingredient names as written by FDA
DANTROLENE SODIUM
Dosage forms
Capsule, Injection, Injection, Powder, For Solution, Injection, Powder, Lyophilized, For Solution, Injection, Suspension
Routes
Intravenous, Oral
Manufacturers / labelers
13
Strengths listed
100 mg/1 · 20 mg/1 · 20 mg/60ml · 25 mg/1 · 250 mg/5ml · 50 mg/1
Brand names in FDA listings
Dantrium, Revonto, Ryanodex Dantrolene Sodium

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 3105

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 017443PH HEALTH1974-01-159
NDA 018264PH HEALTH1979-09-191
ANDA 076856IMPAX LABS2005-03-017
ANDA 076686ELITE LABS INC2005-10-246
ANDA 078378USWM2007-07-242
NDA 205579EAGLE PHARMS2014-07-221
ANDA 204762HIKMA2017-06-191

Official labeling on DailyMed

Showing the 12 most recent of 19 labels.

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.